ReviewMolecular cancer2017

Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.

Hua-Fu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.